MedPath

Effect of inhaled pharmaceutical Penthrox (Methoxyflurane) on pain of limb fracture

Phase 2
Conditions
Condition 1: Sequelae of fracture of arm. Condition 2: Sequelae of other fractures of lower limb.
Sequelae of injury classifiable to S42.-, S52.- and T10
Sequelae of injury classifiable to S82.-, S92.- and T12
Registration Number
IRCT2015111724799N3
Lead Sponsor
Vice chancellor for research, Baqiyatallah University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
100
Inclusion Criteria

Patients older than 18 years who have had limb fractures.
Exclusion criteria: Patients with a history of allergy to inhaled medications, severe injuries, including a ruptured liver and the kidneys, liver disease, kidney disease, patient dissatisfaction and age under 18 and over 80 years as well as patients with a decreased level of consciousness

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Pain. Timepoint: Before intervention, 5, 10, 20 and 30 minutes after intervention. Method of measurement: Questionnaire.
Secondary Outcome Measures
NameTimeMethod
Times of pain reduction. Timepoint: Before intervention, 5, 10, 20 and 30 minutes after intervention. Method of measurement: Questionnaire.
© Copyright 2025. All Rights Reserved by MedPath